Phase Ib study of LXH254+trametinib (TMT) in patients (pts) with NRAS-mutant melanoma.
Filippo de Braud,Christophe Dooms,Rebecca S. Heist,Celeste Lebbe,Martin Wermke,David Planchard,Dirk Schadendorf,Piotr Rutkowski,Jurgen Wolf,Paolo A. Ascierto,Ignacio Gil-Bazo,Shumei Kato,Maria Wolodarski,Meredith McKean,Eva Munoz Couselo,Martin Sebastian,Armando Santoro, Vesselina Cooke, Luca Manganelli,Kitty Wan,Anil Gaur,Tanay S. Samant, Jaeyeon Kim,Giordano Caponigro,Xuan-Mai Couillebault, Michele Moschetta,Adil Daud CANCER RESEARCH（2022）
AI 理解论文
溯源树
样例
